Internist and Nephrologist specialized in GN and Hypertension.Assistant Professor at @kauedu_sa and part time Consultant at @HMG
Jeddah
Joined January 2011
- Tweets17.9K
- Following586
- Followers1.3K
- Likes3.3K
Please join us today and do not miss this important talk
📆Happening today, Friday, November 13, our GlomCon Arabia session titled “Management of ANCA-Associated Vasculitis: Updates and Controversies” by Dr. Georges Nakhoul, MD, MEd, FASN - Cleveland Clinic Foundation, USA
⏰ 6 pm Egypt Time, 7 pm Arab Standard Time.
Other time zones are listed on the flyer above
Join via info below:
Meeting ID: 884 4208 1901
Passcode: 100499
@GlomCon
2
158
Naif Alghamdi retweeted
CONGRESS | #ACR26 | POSTER
Richard Furie presents results from a pooled analysis of the phase III TULIP-1 (NCT02446912), TULIP-2 (NCT02446899), and TULIP-SC (NCT04877691) trials evaluating organ system improvements with anifrolumab (300mg IV Q4W or 120mg SC QW; n = 544) vs placebo (n = 549) in patients with SLE.
At Week 52, a greater proportion of patients treated with anifrolumab vs placebo demonstrated improvements in the SLEDAI-2K mucocutaneous, musculoskeletal, hematological, and immunology systems; treatment differences were observed as early as Weeks 4–8 in some systems. Similarly, higher proportions of patients with anifrolumab vs placebo showed improvement in BILAG-2004 (classified as ≥1 BILAG-2004 score shift from baseline to Week 52) in the musculoskeletal, mucocutaneous, cardiorespiratory, and renal domains.
Follow our live feed for more updates: bit.ly/4iUYXQy
Intended for HCPs. This congress coverage is independently supported through funding from pharmaceutical companies. A full list of our funders can be found on our website. Funders are allowed no influence.
#Lupus #Rheumatology #RheumTwitter #MedEd #MedNews #MedicalCongress @NorthwellHealth
Naif Alghamdi retweeted
#Hyperaldosteronism Remission after Extended #Aldosterone Synthase Inhibition
14-patient cohort: Improvements persisted up to 2 years after treatment cessation. BP ⬇️ by approximately 25 mm Hg, with 23% estimated clinical success.
📌 Aldosterone-to-renin ratio: 210.0 → 1.29 at 1–2 years (n=9)—a 99.2% reduction (95% CI, 98.2–99.6).
nejm.org/doi/full/10.1056/NE…
#ScientificSessions26 #AHA26 @AHAScience
Naif Alghamdi retweeted
Presented at #ScientificSessions26:
In patients with type 2 diabetes and high cardiovascular risk, a systolic blood-pressure target below 120 mm Hg did not result in fewer major cardiovascular events than a target below 140 mm Hg. Full OPTIMAL-DIABETES trial results: nej.md/3UZYKCy
@AHAScience
ALT A graph from the Original Article "Intensive Blood-Pressure Lowering in Patients with Type 2 Diabetes.” The trial name, OPTIMAL-DIABETES, is in parentheses after the title. The graph shows Kaplan–Meier curves for the primary outcome. The trial results are being presented at the American Heart Association Scientific Sessions 2026. The logo of the New England Journal of Medicine is at the bottom.
Naif Alghamdi retweeted
Antihypertensive pharmacotherapy in chronic kidney disease: integrating estimated glomerular filtration rate-based cutoffs, mechanistic insights, and emerging therapeutic pathways
academic.oup.com/ajh/advance…
#WeekendReads
ماشاء الله تبارك الله
موفق ان شاء الله في القادم
حين يندهش الجميع من نتيجة د.معاذ الاستثنائية في اختبار الرخصة الأمريكية، أجدني أراها متوقعة جدًا، فالتميز من أهله غير مستغرب!
عرفت د. معاذ منذ عدة سنوات، وشاهدت رحلته منذ أيام تحضيره لاختبار Step 1، وأعتقد أن ما نراه اليوم ليس إلا ثمرة قرار اتخذه قبل سنوات.
وهنا تكمن الفكرة التي أؤمن بها: كل إنجاز كبير يبدأ بقرار داخلي، والمفارقة أن هذا القرار قد لا يستغرق سوى ثوانٍ معدودة، بينما تمتد آثاره لسنوات.
أتذكر عندما كنت في السنة الرابعة بكلية الطب، وكنت لا أزال مترددًا بشأن خوض تجربة البورد الأمريكي. فتحت حينها كتاب الإحصائيات الخاصة بالقبول، ولاحظت أن الوصول إلى درجة مرتفعة نسبيًا في الاختبار قد يرفع فرص القبول إلى نحو 50%.
أتذكر جيدًا أنني كنت مستلقيًا على سريري قبل النوم حين اتخذت القرار: سأخوض هذه التجربة بكل تفاصيلها، مهما تطلبت من وقت وجهد. كان قرارًا استغرق لحظات، لكنه أطلق رحلة استمرت سنوات حتى اكتملت دائرتها.
وبالعودة للدكتور معاذ، فإن ما يميزه في نظري ليس الاجتهاد وحده، بل قدرته على بناء منظومة شخصية للتعلم والإنجاز (Self-learning system).
منظومة يتحول فيها كل خطأ في بنك الأسئلة إلى فرصة للتعلم، وكل نقطة ضعف إلى شيء يمكن تتبعه وتحسينه، وكل معلومة جديدة إلى معرفة تُراجع وتتعمق مع الوقت.
هذه المنظومة لا تعتمد على الحماس المؤقت، ولا على استنزاف الساعات والجهد، بل على بناء طريقة واسلوب حياة تجعل التقدم مستمرًا، والتعلم تراكميًا، والنتائج ثمرة طبيعية للاستمرارية.
د. معاذ سيواصل تميزه بإذن الله؛ لأنه أدرك مبكرًا خلطة يسهل الحديث عنها، لكن قليلًا من الناس يتبناها ويطبقها:
اتخذ قرارًا واضحًا، ثم ابنِ منظومة واسلوب حياة تخدم هذا القرار، وتجعل الوصول إلى أهدافك أكثر كفاءة، وتحافظ في الوقت نفسه على طاقتك وجهدك ووقتك.
فالقرار قد يُتخذ في ثوانٍ، لكن المنظومة التي تبنيها بعده هي ما يصنع الفارق على مدى سنوات.
أبارك للدكتور معاذ هذا الإنجاز المستحق، وأسأل الله أن يزيده علمًا وتوفيقًا.
543
Naif Alghamdi retweeted
New for 2027: the GlomCon Transplant Scholars Program.
A 10-Month online program dedicated to advancing education in kidney transplantation: From candidate evaluation to post-transplant management, including pathology, protocols, complications, and living donor assessment.
Directed by Nay Seif, MD, MS, and Anshul Bhalla, MD. Built for fellows and practicing nephrologists.
Applications open November 9, 2026.
Learn more at glomcon.org
#Nephrology #KidneyTransplant #NephTwitter #GlomCon
Naif Alghamdi retweeted
The Kidney Pathology Certificate Program returns for its 2027 cohort.
Twelve months, six modules, from biopsy basics to allograft pathology: Live case webinars led by renal pathologists and nephrologists, pre-recorded lectures, and a certificate upon completion of program.
Directed by Vanesa Bijol, MD and Ibrahim Batal, MD.
Applications open on October 26, 2026.
Learn more at glomcon.org
#RenalPathology #Nephrology #Nephropathology #GlomCon
Naif Alghamdi retweeted
Now off to April/BAFF targeting therapies in IgAN by Dr. Ali Mehdi @CleClinicKidney @GlomCon @glomconarabia
Naif Alghamdi retweeted
A brilliant @glomconarabia session on IgA Nephropathy by the amazing Dr. Ali Mehdi @CleClinicKidney @GlomCon
Naif Alghamdi retweeted
We are excited to host another session in the GlomCon Arabia Seminar Series on Friday, October 9th, 2026.
This session will feature an expert presentation by Dr. Ali Mehdi MD, MEd, FACP, FASN, with Dr. Naif Ali A A Alghamdi, MBBS, FASN, CHS (AHSCP) as moderator titled “IgA Nephropathy: Where We Are and Where We Are Going.”
Meeting details:
glomcon.zoom.us
Zoom ID: 884 4208 1901
Passcode: 100499
Find event details at glomcon.org/arabia-glomcon
We invite you to join us for this informative session and connect with colleagues from around the world!
#GlomCon #GlomConArabia #IgANephropathy #Nephrology #KidneyHealth #KidneyEducation #NephrologyEducation #MedicalCommunity #GlobalMedicine
Naif Alghamdi retweeted
We are excited to host another session in the GlomCon Arabia Seminar Series tomorrow Friday, October 9, 2026
This session will feature an expert presentation by Dr. Ali Mehdi “IgA Nephropathy: Where We Are and Where We Are Going”
Meeting details:
glomcon.zoom.us
Meeting ID: 884 4208 1901
Passcode: 100499
@GlomCon @glomconarabia #NephrologyEducation #MedicalCommunity #GlobalMedicine @CleClinicKidney
Naif Alghamdi retweeted
DIALIZE-Outcomes data showed sodium zirconium cyclosilicate did not increase edema, heart failure, hypertension, or weight gain versus placebo in hemodialysis patients, according to study in #ASNKidney360. kidney.pub/KID1330
Naif Alghamdi retweeted
Causes of Infection-Related Glomerulonephritis
From Dr. Hala Kassouf's lecture @glomconarabia
Prof. Hala Kfouri is amazingly discussing this interesting yet confusing topic of infection-related kidney disease @glomconarabia @GlomCon
Naif Alghamdi retweeted
Join us today for an expert presentation by Dr. Hala Kfoury Kassouf titled “Infection-related Kidney Injury: Mechanisms, Implications, and Pathological Insights”
Meeting details:
glomcon.zoom.us
Meeting ID: 884 4208 1901
Passcode: 100499
lnkd.in/d5Ta7sQg
Do not miss this interesting topic coming up Friday
We are excited to host another session in the GlomCon Arabia Seminar Series on Friday, September 18, 2026.
This session will feature an expert presentation by Dr. Hala Kfoury Kassouf, MD, EMBA titled “Infection-related Kidney Injury: Mechanisms, Implications, and Pathological Insights”
Meeting details:
glomcon.zoom.us
Meeting ID: 884 4208 1901
Passcode: 100499
lnkd.in/d5Ta7sQg
We invite you to join us for this informative session and connect with colleagues from around the world!
#GlomCon #GlomConArabia #NephrologyEducation #MedicalCommunity #GlobalMedicine
